Novo Nordisk’s Wegovy made a significant impact on the obesity market when it launched in 2021.
Tirzepatide outpacing Wegovy in the obesity space
January 2, 2025
You may also like
Indices by TradingView
Amazon Launches Infrastructure Region in New Zealand
September 1, 2025
The 10 Public Companies With the Biggest Bitcoin Portfolios
September 1, 2025
Nvidia Ordered to Face Trial Over Alleged Valeo Trade Secret Theft
September 1, 2025
Categories
Indices by TradingView